Grace Therapeutics Inc. Common Stock (GRCE)
FairStock Score: 64/100 — STEADY
| Current Price | $4.29 |
| Market Cap | $6,63,83,576 |
| P/E Ratio | — |
| ROE | -10.22% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology
FairStock Score: 64/100 — STEADY
| Current Price | $4.29 |
| Market Cap | $6,63,83,576 |
| P/E Ratio | — |
| ROE | -10.22% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology